Which is the best PML risk stratification strategy in natalizumab-treated patients affected by multiple sclerosis?

Carla Prezioso, Maria Antonella Zingaropoli, Marco Iannetta, Donatella Maria Rodio, Marta Altieri, Antonella Conte, Vincenzo Vullo, Maria Rosa Ciardi, Anna Teresa Palamara, Valeria Pietropaolo

Research output: Contribution to journalArticlepeer-review

9 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Which is the best PML risk stratification strategy in natalizumab-treated patients affected by multiple sclerosis?'. Together they form a unique fingerprint.

Medicine & Life Sciences